The finding by Millar et al. (1973) that linoleic acid (LA) (in the form of sunflower seed oil) appeared, in a double-blind two-year trial, to exert some moderate influence in reducing the number, severity and duration of acute episodes of multiple sclerosis (MS) in young ambulant patients with recurring bouts of illness, was interpreted initially (Field & Shenton 1975) to depend upon a nontoxic immunosuppressive activity of LA. However, this view has now been shown to be untenable, since after 6 months the immunosuppressive effect of LA (as demonstrated by Mertin in acute tail graft experiments and experimental allergic encephalomyelitis in guinea pigs) passes off (Meyer-Rieneckeret al. 1976 , Field & Joyce 1978 , not only in MS but also in kidney transplantation (McHugh et al. 1977) .
It is now recognized that the effect of LA and ylinolenate is to restore the anomalous inherited constitution ofcell surfaces in MS to normal (Field & Joyce 1978) . MS is 5-20 times more common in near relatives of an MS propositus than in the general population, though our own figures suggest that 40 times is nearer the mark. Children born with 'Thompson's anomaly' (i.e. reduced electrophoretic mobility of the red blood cell with both LA and arachidonic acid (AA) (Field et al. 1977) , if it extends to the oligodendrocyte surface, will lay down abnormal myelin, and there is indeed evidence that the whole brain is affected in MS in regions apart from gross plaques. Such abnormal myelin, once laid down, may be liable to spontaneous (perivenous) breakdown (abiotrophy) or ·to disintegration from nearby antigen-antibody reaction (Wisniewski & Bloom 1975) or other similar disturbance.
Myelination takes place very actively from midfetal life until 5 years of age, and thereafter with diminishing intensity to the age of 16 but (from animal experiments) appears to continue throughout life. Clearly, if the oligodendrocyte surface could be transformed as early as possible after birth, then non-MS susceptible myelin might be laid down. It would seem that the defective myelin 1 Based on paper read to Sectionof Neurology, 2 March 1978.
0141-0768/79/070487-02/$01.00/0 of MS is poorly 'zipped up' in that slippage along the intraperiod line (the original oligodendrocyte surface) is an early change in degeneration in MS. Serious consideration should be given to scanning all children born into MS families, and therefore at small but special risk to develop the disease, with a view to picking out 'candidates' who might then be treated prophylactically with y-linolenate. This is likely to be the major field of effectiveness of this material. The position is in some ways analogous to phenylketonuria, which if recognized at birth is amenable to prevention, but if missed and established is highly refractory to treatment. There is no evidence that polyunsaturated fatty acids (PUFAs) are themselves oncogenic, though when given to animals already inoculated with appropriate tumours they have been shown to increase the 'take percentage' -something quite different from the suggestion that PUFAs themselves produce tumours. Indeed, workers in this field have themselves been at pains to point this out (Hopkins et al. 1976 ). Exhibition of y-linolenate to seemingly normal children may be criticized on psychological grounds but certainly not, on present evidence, on the grounds of oncogenicity.
The geographic distribution of MS with its preponderance in 40°-60°north and south latitudes is a long-established 'fact' in MS, though its simplicity may be deceptive (Kurtzke 1977) . Many correlates with the distribution of MS have been established, some difficult to accord biological significance. However, amongst the putative geographical predisposing factors (GPF) has been the consumption of milk (Agranoff & Goldberg 1974) and this immediately links with the LA and AA considerations outlined above. Twomey (1974) dismisses a correlation with milk consumption on the grounds that 'MS is extraordinarily rare among Africans living on their own continent, though milk is an important food in many parts ofAfrica'. Dean (1977) , like Twomey (1974) , fails to appreciate the critical importance of adequate linoleic acid intake by the child at the critical time when myelination is most intense, i.e. up to about 5 years of age and thereafter more slowly to 16 years of age and even beyond (Yakovlev & Lecours 1967) . It is immaterial that the 'Afrikanders of South Africa ... eat ... a diet ... which has a quite unusually high level of saturated fat -mutton 3 times a day ... and yet they don't get or very seldom get multiple sclerosis' (Dean 1977) . Breast milk is especially rich in fatty acids of long C chains (which are 'essential'). Thus Bentivoglio (1961) shows that linoleic acid (which he considers 'really indispensable') makes up 8.3% (6.8-10.4%) of human milk fat against 1.6% (0.5-2.8%) cow's milk fat. Linoleic acid is also richer in human milk. In a fuller discussion of the essential fatty acid (EFA) content of human milk, Insul & Ahrens (1959) conclude that it is approximately o 1979 The Royal Society of Medicine seven times that found in cow's milk. The question is, how long does linoleic acid-rich breast feeding go on amongst those groups which appear to have a low incidence of multiple sclerosis and for how long is it maintained in our 'advanced' societies? In tropical areas in general and amongst 'primitive' people, breast feeding tends to be prolonged sometimes for years. This will ensure an adequate linoleic acid supply over the critical period and hence good myelin being laid down. Thereafter the intake of saturated animal fat may well be immaterial. It is precisely at the time when myelination is going on most vigorously, and when it needs it the most, that the 40°-60°latitude child is deprived of adequate breast milk. Much more attention should be given to EFA intake in the post-weaning period when artificial food-stuffs are gradually being introduced into the child's diet. If the child is born with 'Thompson's anomaly' then conditions must be especially adverse to the laying down of normal myelin. Once the crucial period is over, then consumption of cow's milk becomes much less important (Field 1979) . In some ways there may be a resemblance to the critical protein needs for proper brain development in the neonate, worked out by Dobbing (1972) .
Furthermore, the content of PDFA in the infant's food is a direct reflection of that of the mother's intake. There is also some evidence (Cash & Berger 1969) that cow's milk may contain specific inhibitors of the conversion of linoleic to arachidonic acid.
The naturally useful cis-forms of EFA may well be converted into trans-forms in certain types of milk food processing. Clearly, as Dick (1976) pointed out, the whole question ofinfant feeding in relation to propensity to develop MS needs prospective study.
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